Apoptosis signal‐regulating kinase‐1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer

Aside from the human epidermal growth factor receptor‐2 (HER2)‐targeting agent trastuzumab, molecular targeting therapy for gastric cancer (GC) has not been established. We previously reported that apoptosis signal‐regulating kinase‐1 (ASK1) was upregulated in human GC and that overexpression of ASK...

詳細記述

保存先:
書誌詳細
出版年:Cancer Sci
主要な著者: Hayakawa, Yoku, Hirata, Yoshihiro, Sakitani, Kosuke, Nakagawa, Hayato, Nakata, Wachiko, Kinoshita, Hiroto, Takahashi, Ryota, Takeda, Kohsuke, Ichijo, Hidenori, Maeda, Shin, Koike, Kazuhiko
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2012
主題:
Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659227/
https://ncbi.nlm.nih.gov/pubmed/23110662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12024
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料